We previously established a ras-oncogene amplified Chinese hamster ovary (CHO) cell line, named ras clone I, as an universal host cell line for oncogene activated production (OAP) system to mass-produce recombinant protein by activation of the cytomegalovirus immediate early (CMV) promoter with ras protein. The λ light chain (C5λ) of human monoclonal antibody HB4C5 is expected to be potentially useful for lung cancer targeting. We generated a C5λ hyper-producing cell line by transfecting ras clone I with the C5λ gene expression plasmid regulated by the CMV promoter, of which productivity was 5.3 times greater than the hyper productive CHO cell line generated by using conventional CHO cells. Introduction of the adenovirus E1A gene into the hyper-producing cell line derived from ras clone I resulted in further 9.5 times enhancement of the productivity, suggesting the synergistic effect of E1A and ras oncogenes on the recombinant protein production driven by the CMV promoter. In addition, intracellular accumulation of C5λ and upregulation of BiP was found in hyper-producing cell lines which were introduced E1A and ras oncogene. This result suggests that excessive intracellular accumulation of C5λ protein, which might be caused by that the amount of produced C5λ in ER is beyond the ability of CHO cells to secrete, might signal the BiP promoter. Our data imply that ras clone I is available as a general host cell for establishing the recombinant protein hyper-producing CHO cells by the OAP system, and suggest that further mass production of recombinant proteins in the OAP system can be possible by clarifying the accurate role of upregulated BiP protein.
Introduction
Mammalian cells are useful host cells for producing complex and/or glycosylated form of recombinant proteins for clinical applications. Chinese hamster ovary (CHO) dihydrofolate reductase (DHFR) cells (Urlaub et al., 1980 ) is a most popularly used host cell line and can mass-produce recombinant proteins by using amplifiable selectable marker gene of DHFR and selection drug of methotrexate (MTX) (KemballCook et al., 1994; Lucas et al., 1996; Kim et al., 1998) . Cockett et al. (1990) have reported glutamine synthetase gene as an another amplifiable marker. By using this marker, productivity of the tissue inhibitor of metalloproteinases (TIMP) reached the level of 110 µg/10 6 cells/day. However, even by using this method, it is laborious and time-consuming task to establish highly productive cell lines. These backgrounds prompted us to development of an oncogene-activated production (OAP) system which enables rapid establishment of recombinant protein hyper-producing cell lines. The OAP system is constructed by introducing a reporter plasmid carrying a gene of interest and effector plasmids carrying oncogenes into host cells. Previously, we have optimized the combination between oncogenes and promoters used in the OAP system. Among the combinations tested, the most suitable combination for efficient protein production was found to be the c-Ha-ras oncogene and the cytomegalovirus immediate early (CMV) promoter (Yano et al., 1994) . In this combination, cHa-ras oncoprotein is thought to affect and enhance the transcriptional ability of the CMV promoter which drives the transcription of the gene of interest. Based on this result, we established ras-oncogene amplified . When the human interleukin 6 gene was transfected into TBR-19, the productivity of human interleulin 6 reached 1.34 µg/10 6 cells/day, which was about 15 times higher than the control value (Teruya et al., 1995) . Furthermore, to rapidly and easily establish recombinant proteins hyper-producing cell lines, we established ras-primed cell line (ras clone I) by introducing c-Ha-ras oncogene into CHO cells and further amplifying the copy number with MTX. Consequently, we have succeeded in establishment of the human interleukin 6 (hIL-6) hyperproducing cell lines by introducing hIL-6 expression plasmid whose expression was driven by the CMV promoter into the ras clone I. Moreover, when the adenovirus E1A oncogene was transfected into the hIL-6 hyper producing ras clone I, peak productivity of one of cloned cell line reached 20.6 µg/10 6 cells/day, which is comparable to the top productivities reached by using mammalian cells (Katakura et al., 1999) . In this report, we evaluated the availability of this OAP system for producing other recombinant protein than hIL-6. A human-human hybridoma clone, HB4C5 was generated by fusing human lymphoblastoid cells and lymphocytes from a lung cancer patient (Murakami et al., 1985) . The HB4C5 cells secrete monoclonal antibody (mAb) which specifically recognizes lung cancer cells, especially adenocarcinoma (Yano et al., 1988) . Even only the λ light chain of this mAb (C5λ) as well as the whole molecule can recognize lung cancer cells, and further has a higher affinity to cancer tissues than the original HB4C5 mAb (Nishimura et al., 1999) . Thus, we constructed the reporter plasmid expressing C5λ protein and attempted to produce C5λ molecule, which can be used for diagnosis of human lung cancer by radioisotope imaging. As a result, C5λ hyperproducing cell line was rapidly and easily established from ras clone I, and the productivity was further increased by introducing E1A oncogene. These results suggest that the ras clone I can be used as a host cell line to rapidly and easily establish the hyper-producing cell lines for various recombinant proteins.
Materials and methods

Construction of expression plasmids
A pRc/CMV vector was purchased from Invitrogen (San Diego, CA, USA). The human c-Ha-ras oncogene (pSK2) was obtained from Japanese Cancer Research Resources Bank (JCRB, Tokyo, Japan). The human c-Ha-ras gene fragment was excised from pSK2 by NotI digestion. The fragment was blunted and subcloned into the SmaI site of pBluescript II, and then excised by HindIII and NotI and cloned into the pRc/CMV, and named pCMV-c-Ha-ras. Next, pSV2-dhfr was digested with PvuII and BamHI to excise SV40-E-dhfr-polyA fragment. This SV40-Edhfr-polyA fragment was blunted and inserted into the NruI site upstream from the CMV promoter of the pCMV-c-Ha-ras plasmid, and named pCMVDc-Ha-ras ( Figure 1B ). pSV2-gpt-gE1A ( Figure 1C ) carrying the E1A gene, which was derived from adenovirus type 12, was a generous gift from Dr K. Onodera (The University of Tokyo). The E1A gene was excised from pSV2-gpt-gE1A with HaeIII and AccI digestion. This E1A gene fragment was blunted and subcloned into SmaI site of pBluescript II, then inserted into the XbaI-ApaI site of pRc/CMV, and named pCMV-E1A ( Figure 1D ). The neo res-istant gene was excised from pRc/CMV vector and named pCMVP. C5λ cDNA (Tachibana et al., 1993) was inserted downstream from the CMV promoter of pCMVP and named pCMVP-C5λ ( Figure 1A ).
Culture media
CHO cells lacking the dhfr gene were cultured in Dulbecco's modified Eagle's medium (DMEM) (Nissui Pharmaceutical, Tokyo, Japan) supplemented with 0.1 mM hypoxanthine (Wako, Osaka, Japan) and 0.016 mM thymidine (Wako) (DMEM-HT) with 5% fetal bovine serum (FBS, Whittaker Bioproducts, Walkersville, MD, USA). The CHO cells transfected with pCMVD-c-Ha-ras was cultured in DMEM with 5% dialyzed FBS (dFBS) and 50 nM methotrexate (MTX) (Sigma, St. Louis, MO, USA). dFBS was prepared by dialyzing FBS using the Spectra/Por membrane (Molecular weight cut: 1000: Specrum, Houston, TX, USA). Cells were cultured in 5% CO 2 /95% air atmosphere at 37 • C.
Cell culture and DNA transfection
CHO cells were grown in DMEM supplemented with 5% FBS. Transfection into CHO cells was carried out by the calcium phosphate transfection protocol (Chen et al., 1987) . Briefly, 3 × 10 5 cells were plated onto 60-mm plastic dishes and grown overnight. Fifteen µg of expression plasmid were mixed with 25 µl of 0.25 M CaCl 2 and 250 µl of 2 × BBS, and filled up to a final volume of 500 µl with water, then incubated at room temperature for 30-60 min. This calcium phosphate DNA solution was added dropwise onto the dishes, and swirled to mix completely. Cells were cultured for 15-24 h at 3% CO 2 /97% air atmosphere. After the cells were washed twice with PBS, fresh medium was added.
Establishment of recombinant CHO cells
To establish stable cell lines expressing recombinant protein by conventional calcium phosphate coprecipitation method, CHO cells were cotransfected with 13.5 µg of pCMVP-C5λ and 1.5 µg of pSV2-bsr. When confluence was reached, 5 µg ml −1 of blasticidin S (Funakoshi, Tokyo, Japan) was added to the medium. Single clones were isolated using the limiting dilution cloning, then were evaluated for C5λ productivity to select the clone showing the highest productivity. We previously established a ras amplified CHO cell line named ras clone I, which was isolated from the CHO cells transfected with pCMVD-c-Haras (Katakura et al., 1999) . In this study, pCMVP-C5λ was introduced into the ras clone I as above. Then the clone showing the highest productivity of C5λ protein was selected by limiting dilution cloning. This clone was further transfected with pCMV-E1A plasmid along with the selection marker of pSV2-hph. Selection was performed using 200 µg ml −1 of hygromycin B (Wako). Single clone was isolated by limiting dilution cloning and assessed its productivity.
Determination of concentration of the secreted C5λ protein
Cell-culture supernatants were assayed with sandwich ELISA using goat anti-human λ polyclonal antibody (TAGO, Burlingame, CA, USA) as capturing antibody and peroxidase labeled goat anti-human λ polyclonal antibody (TAGO) as detecting antibody. The human λ chain (Gelco Diagnostic, Shreveport, LA, USA) was used as a standard for calibration of the assay.
Northern analysis for C5λ and E1A mRNA
Total RNA was isolated from each subconfluent culture using the TRIzol reagent (Gibco BRL, Gaithersburg, MD). Six µg of total RNA was subjected to 1.2% agarose gel electrophoresis under denaturing condition. Separated RNA was transferred to Hybond-N + membrane (Amersham, Buckinghamshire, UK), and hybridized with C5λ or E1A fragment labeled with fluorescein-dCTP by Random prime labeling module (Amersham). Subsequently, hybridized bands were visualized by Gene Images CDP-Star detection module (Amersham). After stripping the C5λ or E1A probe, the same membrane was rehybridized with β-actin probe (Wako).
Western blotting
Cell-culture supernatants or cell pellets corresponding to equivalent cell number were prepared. These samples were denatured in 1 volume of 2× sample buffer (50 mM Tris-HCl, 10% glycerol, 2% SDS, 2% 2-melcaptoethanol, 0.1% BPB) by boiling for 5 min, and then run on 10% SDS/PAGE denaturing gel. Separated proteins were transferred to nitrocellulose membrane (Schlicher and Shuell, Dassel, Germany) by electroblotting. C5λ protein was detected with the peroxidase-labeled anti-human λ chain antibody (TAGO) and visualized with enhanced chemiluminescence (ECL: Amersham). Figure 4 . Expression of C5λ and E1A mRNA in each C5λ producing cell lines. RNA blots were probed with a C5λ or E1A probe (top panels) and with a β-actin probe as internal control (bottom panels). The amount of C5λ mRNA in wtIE-13 (ras + E1A) was quantitatively determined by Kodak EDAS system and normalized against that in wtI-16 (ras) (lane 2).
Northern analysis of BiP mRNA
mRNA was prepared by using a QuickPrep Micro mRNA Purification Kit (Pharmacia, Uppsala, Sweden). BiP cDNA fragment amplified by PCR using primers (5 -ACTGGAATTCCTCCTGCTCC-3 and 5 -GTTCCTGGTATCAATGCGC-3 ) was labeled with fluorescein-dCTP by using the Random prime labeling module (Amersham). Blotting, hybridization and detection procedures were performed as described above. Band intensities were quantified with the Kodak EDAS system (Eastman Kodak Co., Rochester, NY, USA).
Results and discussion
Expression of C5λ protein under a control of the CMV promoter activated by oncogene
We introduced pCMVP-C5λ which express C5λ protein under the control of the CMV promoter, along with the selection marker gene of pSV2-bsr into the ras clone I. After selection with blastcidin S, C5λ hyper-producing cell lines were obtained by limiting dilution cloning. Concentration of secreted C5λ protein was tested by sandwich ELISA. Productivities for recombinant CHO cell lines generated by conventional method or OAP system were listed in Table I . Compared with a control highest producing cell line (wt-26) generated by using CHO cells as host cells, the productivity of C5λ protein for a recombinant CHO cell line (wtI-16) generated by introducing C5λ expression plasmid into the ras clone I increased 5.3 fold. Furthermore, E1A oncogene was introduced into the wtI-16, and then the highest producing clone was selected by limiting dilution cloning. A highest producing recombinant CHO cell line (wtIE-13) which was generated by introducing E1A gene into the wtI-16 secreted C5λ protein 51 times greater than wt-26. Next, we assessed the proliferative potential of these recombinant CHO cells, because recombinant protein hyper-producing cells frequently show slower growth rates. However, the growth rate of wtIE-13 was nearly as high as that of wt-26 (Figure 2) . Moreover, Figure 3 shows the accumulated production of C5λ protein by wt-26 (control), wtI-16 (ras) and wtIE-13 (ras + E1A) in long-term culture. In this figure, a noteworthy point is that the straight increase of the accumulated amount of C5λ protein in wtIE-13 demonstrates that hyperproducing cell lines stably can produce recombinant proteins even in long-term culture. Thus, these results indicate that wtIE-13 can be available for mass production of C5λ protein. In some expression systems, high overexpression of recombinant protein has been reported to lead to the production of inactive protein resulting from aggregation, misprocessing and misfolding, etc. We have analyzed the biological activity of C5λ produced from ras amplified CHO cells (ras clone I). As a consequence, tumor radioimmunoimaging experiments in LC6 (lung squamous cell carcinoma line)-xenografted nude mice by the injection of 125 I-labeled recombinant C5λ, which produced from ras clone I, gave tumor-specific and recombinant human λ light chain-dependent images on day 5 postinjection (manuscript in preparation). This result indicates that C5λ produced from ras clone I can be potentially useful for lung cancer targeting. Figure 5 . Evaluation of the extracellular and intracellular amounts of C5λ proteins. Secreted C5λ protein into the culture supernatant (Ex) and accumulated C5λ protein inside the cell (In) in C5λ producing cell lines (wt-26, wtI-16, wtIE-13) were analyzed by western blot analysis as described in the section Materials and Methods.
Evaluation for availability of the OAP system at the transcription level
In order to evaluate the availability of the OAP system at the transcription level, total RNA was prepared from these cell lines and subjected to Northern blot analysis (Figure 4) . The results indicate that C5λ transcription was enhanced by primed ras in wtI-16 and further augmented by simultaneous introduction of ras and E1A in wtIE-13. This result is consistent with the result that C5λ productivity was enhanced by ras, and synergistically by ras and E1A (Table I ). These results demonstrate that recombinant protein hyper-producing ability of the recombinant CHO cells generated by the OAP system can be explained by the transcriptional activation of the CMV promoter by oncogenes, leading to augmented transcription of the target gene inserted downstream from the CMV promoter. Furthermore, this result shows that ras and E1A synergistically enhance the transcriptional ability of the CMV promoter, suggesting that ras-signaling cascade can be enhanced by E1A, and that all of target genes inserted downstream from the CMV promoter can be overexpressed in the OAP system.
Evaluation for availability of the OAP system at the translation and translocation level
In order to evaluate the availability of the OAP system at the translation and translocation level, we examined the intracellular and extracellular amount of recombinant protein by Western blotting. As shown in Figure 5 , the extracellular amount of C5λ protein increased by introduction of ras, and synergistically augmented by simultaneous introduction of ras and E1A, which is consistent with the result of sandwich ELISA (Table I ). Furthermore, we tested for the amount of intracellular C5λ protein. Although C5λ protein can not be detected intracellularly in wt-26 and wtI-16, C5λ protein greatly accumulated intracellularly in wtIE-13. To evaluate the augmented production and its concurrent intracellular accumulation of C5λ, C5λ mRNA level shown in Figure 4 were quantified with the Kodak EDAS system. As a result, C5λ mRNA level in wtIE-13 was about 11.5 times higher than that in wtI-16. On the other hand, the productivity of C5λ protein in wtI-16 and wtIE-13 were 0.48 µg/10 6 cells/day and 4.6 µg/10 6 cells/day (Table I) , and a ratio of the productivity of wtIE-13 to wtI-16 was 9.5 times. This induction value of the C5λ productivity was a little lower than the value of transcriptional induction level in wtIE-13. These results indicate that promoter activation by ras/E1A in the OAP system does not exactly lead to full augmentation of protein production. On the basis of these findings, we speculate that the amount of produced protein is beyond the ability of CHO cells to secrete, and then excess amounts of C5λ protein may be accumulated intracellularly in wtIE-13.
Accumulation of intracellular C5λ protein
We anticipated that large amount of intracellular accumulation of C5λ protein observed in wtIE-13 might induce expression of BiP (heavy chain binding protein) dependent upon the ER overload (Kozutsumi et al., 1988) . To assess this possibility, we evaluated for the expression of BiP mRNA by Northern blotting. As shown in Figure 6 , BiP transcript was shown to be approx. 2-times greater in wtIE-13 than other recombinant CHO cells. The mammalian BiP promoter is involved in stress-inducible BiP expression (Chang et al., 1989; Li et al., 1994 Li et al., , 1997 . Thus, excessive intracellular accumulation of C5λ protein might signal the BiP promoter, resulted in the upregulated transcription of BiP. The stressed ER is linked to the UPR (unfolded protein response) pathway as well as to the activation of the NF-κB transcription factor complex. Pahl et al. has mentioned that the pathway mediated by NF-κB activation may sense the amount of protein processed through the ER and signal ER overload, and that such a signal could trigger increased ER biosynthesis to relieve the cognition in this organelle (Pahl et al., 1995) . Thus, the accurate role of upregulated BiP protein with ER overload must be elucidated, which would lead to enable us to hyper-produce the recombinant protein in the OAP system. 
Conclusion
In conclusions, we have established a useful host cell line termed ras clone I, which enable us to rapidly establish recombinant proteins hyper-producing cell lines. In this study, we clarified that C5λ protein can be produced at 5.3-fold higher levels when using ras clone I as host cells as compared to the conventional method. Furthermore, when E1A oncogene was introduced into the recombinant ras clone I expressing C5λ protein, the C5λ productivity was boosted up to 51-fold higher than the control. The growth potential of C5λ hyper-producing cell lines was maintained for at least 30 days, indicating that mass production of C5λ protein is possible by using this cell line. Moreover, in recombinant proteins hyper-producing cell lines such as wtIE-13, a large amount of proteins were accumulated inside the cells, which might be leading to upregulation of BiP. This suggests that further mass production of recombinant proteins in the OAP system can be possible by clarifying the accurate role of upregulated BiP protein and elucidating these speculations.
